BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its board of ...
Zacks.com on MSN11h
BD Stock Falls in Pre-Market Despite Q1 Earnings Beat, Gross Margin UpBecton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $3.43 in the first ...
Becton Dickinson (NYSE:BDX) stock was down 3% in morning trading Thursday, the day after the company released its fiscal Q1 earnings report and confirmed it was splitting the company into two separate ...
BD (NYSE: BDX) announced that its board unanimously authorized management to pursue the separation of its Life Sciences business.
Becton Dickinson plans to spin off its Biosciences and Diagnostic Solutions unit, targeting a fiscal 2026 completion, while updating FY25 revenue guidance.
Consensus is $14.35. Sees FY25 revenue $21.7B-$21.9B vs. previous view $21.9B-$22.1B, consensus $21.93B.Maximize Your Portfolio with Data ...
The Financial Times reports today that an activist investor wants BD (NYSE:BDX) to sell off its Life Sciences business unit.
At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at 1-800-839-2486 for domestic calls and area ...
HDR, Flad Architects, Gensler, HOK, DGA, and Payette top Building Design+Construction's ranking of the nation's largest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback